Related Experiment Video
Updated: Jul 31, 2026

Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Published on: September 11, 2012
Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer
1Division of Hematology-Oncology, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, OH 44106-4937, USA.
Abstract:
We have previously shown that human cancer cells deficient in DNA mismatch repair (MMR) are resistant to the chemotherapeutic methylating agent temozolomide (TMZ) and can be sensitized by the base excision repair (BER) blocking agent methoxyamine (MX) [21]. To further characterize BER-mediated repair responses to methylating agent-induced DNA damage, we have now evaluated the effect of MX on TMZ-induced DNA single strand breaks (SSB) by alkaline elution and DNA double strand breaks (DSB) by pulsed field gel electrophoresis in SW480 (O6-alkylguanine-DNA-alkyltransferase [AGT]+, MMR wild type) and HCT116 (AGT+, MMR deficient) colon cancer cells. SSB were evident in both cell lines after a 2-h exposure to equitoxic doses of temozolomide. MX significantly increased the number of TMZ-induced DNA-SSB in both cell lines. In contrast to SSB, TMZ-induced DNA-DSB were dependent on MMR status and were time-dependent. Levels of 50 kb double stranded DNA fragments in MMR proficient cells were increased after TMZ alone or in combination with O6-benzylguanine or MX, whereas, in MMR deficient HCT116 cells, only TMZ plus MX produced significant levels of DNA-DSB. Levels of AP endonuclease, XRCC1 and polymerase beta were present in both cell lines and were not significantly altered after MX and TMZ. However, cleavage of a 30-mer double strand substrate by SW480 and HCT116 crude cell extracts was inhibited by MX plus TMZ. Thus, MX potentiation of TMZ cytotoxicity may be explained by the persistence of apurinic/apyrimidinic (AP) sites not further processed due to the presence of MX. Furthermore, in MMR-deficient, TMZ-resistant HCT116 colon cancer cells, MX potentiates TMZ cytotoxicity through formation of large DS-DNA fragmentation and subsequent apoptotic signalling.
Insights
Methoxyamine (MX) enhances temozolomide (TMZ) chemotherapy by increasing DNA damage in cancer cells. This potentiation, particularly in MMR-deficient cells, leads to DNA fragmentation and apoptosis, overcoming resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair Mechanisms
Background:
- DNA mismatch repair (MMR) deficient cancer cells exhibit resistance to temozolomide (TMZ).
- Methoxyamine (MX), a base excision repair (BER) inhibitor, can sensitize these cells to TMZ.
- Understanding BER's role in response to TMZ-induced DNA damage is crucial for optimizing cancer therapy.
Purpose of the Study:
- To investigate the effect of MX on TMZ-induced DNA single-strand breaks (SSB) and double-strand breaks (DSB).
- To characterize the role of MMR status in the formation of TMZ-induced DNA damage in colon cancer cells.
- To elucidate the mechanism by which MX potentiates TMZ cytotoxicity, especially in MMR-deficient cells.
Main Methods:
- Evaluation of TMZ-induced SSB using alkaline elution in SW480 (MMR proficient) and HCT116 (MMR deficient) colon cancer cells.
- Assessment of TMZ-induced DSB using pulsed-field gel electrophoresis in both cell lines.
- Analysis of DNA repair protein levels and enzymatic activity in response to TMZ and MX treatment.
Main Results:
- MX significantly increased TMZ-induced SSB in both MMR proficient and deficient cells.
- TMZ-induced DSB were dependent on MMR status and time; MMR-deficient cells showed significant DSB only with TMZ plus MX.
- MX and TMZ combination inhibited DNA cleavage activity, suggesting persistence of apurinic/apyrimidinic sites, leading to DS-DNA fragmentation and apoptosis in MMR-deficient cells.
Conclusions:
- Methoxyamine potentiates temozolomide cytotoxicity by increasing DNA single-strand breaks and promoting double-strand break formation, particularly in MMR-deficient colon cancer cells.
- The mechanism involves the persistence of unrepaired apurinic/apyrimidinic sites, leading to significant DNA fragmentation and subsequent apoptotic signaling, thereby overcoming TMZ resistance.
Related Concept Videos
Drugs that Stabilize Microtubules
Abnormal Proliferation
Drugs that Destabilize Microtubules
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
Inhibitors of Bacterial DNA Synthesis

